REQUEST A DEMO
Total
USD $0.00
Search more companies

Ferlact Biotech S.A.S. (Ecuador)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Full name: Ferlact Biotech S.A.S. Profile Updated: June 16, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Ferlact Biotech S.A.S. is an enterprise in Ecuador, with the main office in Quito. It operates in the Research and Development in Biotechnology (except Nanobiotechnology) industry. The company was established on March 23, 2022. Ferlact Biotech S.A.S. currently employs 2 (2024) people. There was a net sales revenue increase of 268.97% reported in Ferlact Biotech S.A.S.’s latest financial highlights for 2024. Over the same period, its total assets grew by 271.52%. The enterprise’s net profit margin increased by 192.14% in 2024.

Headquarters
Calle S3D, E2163
Quito; Pichincha;

Contact Details: Purchase the Ferlact Biotech S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Ferlact Biotech S.A.S. report to view the information.
Registered Capital:
Purchase the Ferlact Biotech S.A.S. report to view the information.
Financial Auditors:
Purchase the Ferlact Biotech S.A.S. report to view the information.
Incorporation Date:
March 23, 2022
Key Executives
Purchase this report to view the information.
Manager
Company Performance
Financial values in the chart are available after Ferlact Biotech S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
268.97%
Total operating revenue
268.97%
Operating profit (EBIT)
94.52%
EBITDA
N/A
Net Profit (Loss) for the Period
94.29%
Total Assets
271.52%
Total Equity
-10.4%
Operating Profit Margin (ROS)
191.94%
Net Profit Margin
192.14%
Return on Equity (ROE)
170.63%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?